Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular Vesicles.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular Vesicles.
- Published In:
- Journal of extracellular biology, 4(11), e70099 (2025)
- Authors:
- Zhang, Yuefei, Han, Jianyi, Wu, Wei, Dang, Bobo
- Database ID:
- RPEP-14562
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14562APA
Zhang, Yuefei; Han, Jianyi; Wu, Wei; Dang, Bobo. (2025). Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular Vesicles.. Journal of extracellular biology, 4(11), e70099. https://doi.org/10.1002/jex2.70099
MLA
Zhang, Yuefei, et al. "Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular Vesicles.." Journal of extracellular biology, 2025. https://doi.org/10.1002/jex2.70099
RethinkPeptides
RethinkPeptides Research Database. "Oral Delivery of Semaglutide and Tirzepatide Using Milk-Deri..." RPEP-14562. Retrieved from https://rethinkpeptides.com/research/zhang-2025-oral-delivery-of-semaglutide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.